plerixafor
ItalyDrugs containing this active substance
-
It is used to promote the release and collection of stem cells from the blood, which can then be stored for a future transplant. It is indicated for adults with lymphoma or multiple myeloma and for children between 1 and 18 years of age with lymphoma or solid tumors.
Form: solution for injection
Active substance Dosage plerixafor - ATC: L03AX16
Manufacturer: SANOFI B.V.
-
This medicine is used to promote the release of stem cells into the blood (mobilization) to allow for their collection, storage, and subsequent transplantation. It is used in adults with lymphoma or multiple myeloma and in children between 1 and 18 years of age with lymphoma or solid tumors.
Form: solution for injection
Active substance Dosage plerixafor - ATC: L03AX16
Manufacturer: ACCORD HEALTHCARE, S.L.U.
-
It is used to promote the release and collection of stem cells into the blood, which can then be stored for a future transplant. It is indicated for adults with lymphoma or multiple myeloma and for children aged 1 to 18 years with lymphoma or solid tumors.
Form: solution for injection
Active substance Dosage plerixafor - ATC: L03AX16
Manufacturer: EG S.P.A.
-
It is used to promote the release and collection of stem cells into the blood, which can then be stored for a future transplant. It is indicated for adults with lymphoma or multiple myeloma and for children aged 1 to 18 years with lymphoma or solid tumors.
Form: solution for injection
Active substance Dosage plerixafor - ATC: L03AX16
Manufacturer: TILLOMED ITALIA SRL